WeTrials is proud to announce that Beat Childhood Cancer (BCC) at Penn State College of Medicine has implemented the WeTrials AI-powered patient engagement platform. Together, we are helping families discover, understand and engage with pediatric cancer clinical research opportunities across BCC’s international study portfolio.

Beat Childhood Cancer is an international pediatric cancer research consortium comprising more than 50 hospitals and research institutions across North America, South America and Europe. Through this collaboration, families now have a centralized destination to explore BCC’s studies and navigate the clinical research journey with greater confidence and understanding.

Families can access the platform at https://research.beatcc.org/.

A Centralized Destination for Families

Awareness and understanding remain some of the biggest barriers to clinical trial participation. The WeTrials platform is designed to lower those barriers by giving families a single, patient-friendly place to learn about the research opportunities available to them.

Through the platform, families of children with cancer can access:

• Simplified study information that translates complex clinical research into clear, understandable language.
• Personalized educational and support experiences tailored to where each family is in their journey.
• AI-powered engagement tools designed to help families explore their options and ask questions with greater confidence.

The platform supports Beat Childhood Cancer’s growing portfolio of clinical research studies across its international network of participating institutions—helping connect more families with research opportunities and educational resources at every step.

Putting Families First: Perspectives from Leadership

Dr. Giselle Saulnier-Sholler, Chair of Beat Childhood Cancer:
“At Beat Childhood Cancer, we are continually looking for ways to better serve children and families while advancing pediatric cancer research. This collaboration helps make clinical trial opportunities more visible and understandable while helping us continuously improve how we support families throughout their clinical research journey. By making research information easier to access and understand, we can help families make more informed decisions about potential treatment and clinical trial opportunities.”

Romeo De Leon, CEO and Co-Founder of WeTrials:
“Clinical research teams have made tremendous advances in developing innovative therapies for children with cancer, yet awareness and understanding remain significant barriers to participation. Together with Beat Childhood Cancer, we’re helping bridge the gap between groundbreaking research and the families it was designed to serve. Our shared goal is to make clinical research opportunities easier to discover, understand and access.”

Looking Ahead

This launch reflects Beat Childhood Cancer’s commitment to patient-centered innovation in clinical research, and the potential for AI-powered engagement technologies to improve awareness, understanding and participation in pediatric oncology studies.

As the partnership grows, WeTrials plans to introduce future innovations—including multilingual capabilities and additional AI-powered engagement experiences—to further support families and research teams across the Beat Childhood Cancer network.

Read the full press release: https://www.newswise.com/articles/beat-childhood-cancer-at-penn-state-college-of-medicine-launches-wetrials-ai-patient-engagement-platform